High Healthcare Utilization in a Severe Asthma Population Despite Use of High Dose ICS/LABA

被引：0
|
作者：
Castro, M. [1 ]
Reaven, N.
Funk, S.
Jarjour, N. [2 ]
机构：
[1] Washington Univ, St Louis, MO 63130 USA
[2] Univ Wisconsin, Madison, WI 53706 USA
来源：
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE | 2009年 / 179卷
关键词：
D O I：
暂无
中图分类号：
R4 [临床医学];
学科分类号：
1002 ; 100602 ;
摘要：
A1275
引用
收藏
页数：1
相关论文
共 50 条
  • [41] VERY HIGH DOSE CORTICOSTEROID TREATMENT FOR SEVERE ACUTE ASTHMA
    BRITTON, MG
    COLLINS, J
    BROWN, D
    [J]. BRITISH JOURNAL OF DISEASES OF THE CHEST, 1976, 70 (03): : 214 - 215
  • [42] Comparing Costs and Healthcare Resource Utilization (HCRU) Using LAMA versus LABA/ICS at Treatment Initiation for COPD: Findings from CITRUS (Comparing the Incidence of Tiotropium and ICS/LABA in Real-World Use in South Korea) Study
    Choi, Kwang Yong
    Il Kim, Hwan
    Rhee, Chin Kook
    Ha Yoo, Kwang
    Park, Yong Bum
    Kim, Youlim
    Lee, So Eun
    Kim, Jung-Ae
    Il Hwang, Yong
    [J]. INTERNATIONAL JOURNAL OF CHRONIC OBSTRUCTIVE PULMONARY DISEASE, 2024, 19 : 1661 - 1671
  • [43] Modulating the Level of ICS in Triple ICS/LABA/LAMA FDC: Effect Against Inflammation in a Human Ex Vivo Model of Severe Eosinophilic Asthma
    Rogliani, P.
    Ora, J.
    Motta, E.
    Melis, E.
    Facciolo, F.
    Calzetta, L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [44] The Burden of Asthma in Subjects Receiving Low-Dose ICS/LABA - an Analysis from a Real World Survey
    Gruffydd-Jones, K.
    Fageras, M.
    Hamblin, A.
    Draffan, L.
    Mestdagh, N.
    Sidaway, M.
    Sheikh, A.
    Small, M.
    Haq, A.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2022, 205
  • [45] Pattern of asthma control and inhaled corticosteroid (ICS) use in an Australian asthma population
    Peters, Matthew
    Sawyer, Susan
    Flood, Paul
    Everett, Peter
    Reddel, Helen
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2013, 42
  • [46] High prevalence of severe asthma in a large random population study
    Mincheva, Roxana
    Ekerljung, Linda
    Bossios, Apostolos
    Lundback, Bo
    Lotvall, Jan
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2018, 141 (06) : 2256 - +
  • [47] Healthcare resource use and costs of severe, uncontrolled eosinophilic asthma in the UK general population
    Kerkhof, Marjan
    Tran, Trung N.
    Soriano, Joan B.
    Golam, Sarowar
    Gibson, Danny
    Hillyer, Elizabeth V.
    Price, David B.
    [J]. THORAX, 2018, 73 (02) : 116 - 124
  • [48] AS-NEEDED ICS-LABA IN MILD ASTHMA: REDUCES SHORT-TERM RISK OF SEVERE EXACERBATION AFTER A SINGLE DAY OF INCREASED USE
    Khaw, Chuen Ryan
    [J]. THORAX, 2021, 76 (04) : 423 - 423
  • [49] Modulating the Level of ICS in Triple ICS/LABA/LAMA FDC: Effect Against Airway Hyperresponsiveness in a Human Ex Vivo Model of Severe Eosinophilic Asthma
    Rogliani, P.
    Ora, J.
    Frugoni, C.
    Melis, E.
    Facciolo, F.
    Calzetta, L.
    [J]. AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2023, 207
  • [50] AUSTRI and VESTRI LABA Safety studies subgroup analysis of asthma exacerbations and SAEs comparing FSC and FP by ICS dose
    Raphiou, Ibrahim
    Kral, Kenneth
    Brealey, Noushin
    Prillaman, Barbara
    Emmett, Amanda
    Baidoo, Carlotte
    Mancuso, Maria
    Pascoe, Steven
    [J]. EUROPEAN RESPIRATORY JOURNAL, 2017, 50
12345